UK market conditions are currently challenging for technology inventors seeking their next injection of funding. But founders with validated projects that are presented in the right way can find success among investors looking to park their capital in healthtech.
That was view of Ali Lindsay, investments director at Maven Capital Partners, as she addressed BioWales 2025 from the conference’s investor panel
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?